Capping and Capture Reagents for HPLC-Free Peptide Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for solid-phase peptide synthesis face challenges in efficiently purifying full-length peptides due to the co-elution of truncated sequences and the use of expensive or complex reagents, which often leave residual moieties or require harsh cleavage conditions, complicating the purification process.
Innovation Solution
The use of a capping and capture reagent comprising a carboxylic acid or activated carboxylic acid as the capping moiety and a protected carbonyl group as the capture moiety, allowing for efficient capping and separation of failure peptide sequences during synthesis, followed by binding to a resin support for easy removal.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional capping reagents (e.g., acetic anhydride) are used to deactivate unreacted amino groups, then complete deactivation of free amines is achieved, but truncated sequences still co-elute with full-length product during HPLC purification
Solution Approach 1:
The patent divides the capping function into two separate functional groups within a single reagent molecule: a capping moiety (e.g., acetyl group) that deactivates unreacted amino groups, and a capture moiety (e.g., biotin) that provides selective binding capability. This segmentation allows the reagent to perform both capping and purification functions simultaneously, resolving the contradiction between achieving complete deactivation and enabling effective separation of truncated sequences.
Solution Approach 2:
The invention uses composite reagent molecules that combine chemically distinct functional groups (capping and capture moieties) into a single entity. Examples include biotinylated acetic anhydride or other conjugated structures where one part performs acylation while the other part enables affinity capture. This composite approach allows both functions to work together in a coordinated manner during the purification process.
2Manufacturing precision
If expensive or complex capping reagents are used to improve purification, then better separation of truncated sequences is achieved, but reagent cost and synthesis complexity increase
Solution Approach 1:
The patent creates universal capping reagents that perform multiple functions: standard acylation of unreacted amines, incorporation of affinity handles for purification, and compatibility with automated synthesis systems. These multi-functional reagents can be used across different peptide synthesis projects without requiring custom reagent development for each application, reducing both cost and complexity while maintaining high purification efficiency.
Solution Approach 2:
The invention employs relatively simple and inexpensive reagent molecules (such as biotinylated derivatives of common capping reagents) that can be readily synthesized or purchased. These reagents are used in stoichiometric or near-stoichiometric amounts and are consumed in the process, but their low cost and ease of preparation make them economically viable for routine peptide synthesis and purification applications.
3Manufacturing precision
If preparative HPLC is used for peptide purification, then high purity full-length peptide is obtained, but the process is time-consuming and requires large amounts of solvent
Solution Approach 1:
The patent extracts the purification function from the traditional HPLC process by incorporating an affinity capture moiety directly into the capping reagent. This allows truncated sequences to be selectively bound and removed from the solution through simple affinity chromatography or precipitation, separating the purification step from the complex HPLC process and dramatically reducing time and solvent requirements while maintaining high purity.
Solution Approach 2:
The capture moiety (e.g., biotin) acts as an intermediary that facilitates selective binding of truncated sequences to a solid support (e.g., streptavidin-coated beads). This intermediary mechanism enables efficient separation without requiring the complex interactions and gradients needed in HPLC, simplifying the purification process to a single binding-washing-elution cycle.
4Manufacturing precision
If terminal modification with purification handle is performed, then selective isolation of full-length peptide is enabled, but residual moieties or harsh cleavage conditions contaminate the final product
Solution Approach 1:
Instead of modifying the full-length peptide with a purification handle and then removing it, the invention inverts the approach by modifying only the truncated sequences with the capture moiety. This causes the unwanted truncated products to be selectively bound and removed, while the full-length peptide remains unmodified and in solution, eliminating the need for cleavage steps and avoiding contamination from residual handles or harsh cleavage conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the need for time-consuming preparative HPLC, saves solvent, and ensures the final product is free of residual moieties, facilitating rapid and cost-effective purification of full-length peptides.
Implementation Method 1
a capping and capture reagent comprising a capping moiety and a capture moiety, wherein said capping moiety is a carboxylic acid or an activated carboxylic acid
Implementation Method 2
said capture moiety is a protected carbonyl group... binding to a resin support for easy removal
Data Source
AI summary
The present disclosure relates to the use of a capping and capture reagent in solid phase peptide synthesis. The present disclosure further relates to a method of solid phase peptide synthesis, wherein a capping and capture reagent according to the present disclosure is used. The present disclosure further relates to a method for purification of a (full-length) synthetic peptide via use of a capping and capture reagent according to the present disclosure. The present disclosure also relates to a kit comprising a capping and capture reagent according to the present disclosure and an amino oxy resin or a hydrazine resin and the use of the kit.